Cantrill J A
School of Pharmacy and Pharmaceutical Sciences, University of Manchester, UK.
J Clin Pharm Ther. 2000 Oct;25(5):341-6. doi: 10.1046/j.1365-2710.2000.00297.x.
The British National Formulary (BNF) is an independent professional publication which is highly respected and widely used by health care professionals in the U.K. In addition, it has been translated into several languages for use outside the U.K. A set of prescribing indicators has been developed to assess the appropriateness of long-term prescribing in U.K. general practice, using the BNF as the 'gold standard'.
The objective of this paper is to gain an understanding of why GPs may prescribe outside the recommendations given in the BNF.
Twenty-two GPs were interviewed about a range of instances of potentially inappropriate prescribing for 101 patients under their care. These cases had been identified through the application of a set of prescribing indicators to the medical records of individual patients. The interview transcripts were repeatedly reviewed to identify cases where the GP felt that his/her prescribing was appropriate, even though it did not adhere to the guidance in the BNF.
The indicators which looked at total daily dose, recording of a valid indication, prescribing drugs of limited clinical value, generic prescribing and use of a potentially hazardous drug-drug combination all identified situations in which the GP would prescribe outside of the BNF guidance. In some cases they felt that the guidance was difficult to apply in clinical practice and in others they were either unaware of or did not believe it to be based on sound evidence. This may either be dictated by individual patient need or a consistent approach to prescribing a specific drug, based on their own clinical experience.
This study has demonstrated that GPs will sometimes prescribe outside BNF guidance. With the continuing effort to improve prescribing in general practice, it is essential for those trying to influence prescribing behaviour to understand the complexity of this decision-making process. This should help inform the design and implementation of strategies to change behaviour in this area.
《英国国家处方集》(BNF)是一份独立的专业出版物,在英国备受医疗保健专业人员的尊重和广泛使用。此外,它还被翻译成多种语言供英国以外地区使用。已制定了一套处方指标,以《英国国家处方集》为“金标准”,评估英国全科医疗中长期处方的适宜性。
本文的目的是了解全科医生为何可能会开出超出《英国国家处方集》建议的处方。
就其照护的101名患者一系列潜在不适当处方的情况,对22名全科医生进行了访谈。这些病例是通过将一套处方指标应用于个体患者的病历而确定的。对访谈记录进行了反复审查,以确定全科医生认为其处方是合适的病例,即使这些处方不符合《英国国家处方集》的指导。
那些关注每日总剂量、有效适应症记录、开具临床价值有限的药物、通用名处方以及使用潜在有害的药物-药物组合的指标,均识别出了全科医生会开出超出《英国国家处方集》指导的情况。在某些情况下,他们认为该指导在临床实践中难以应用,而在其他情况下,他们要么不知道该指导,要么不认为其基于可靠证据。这可能是由个体患者的需求决定的,也可能是基于他们自己的临床经验对特定药物进行处方的一贯方法。
本研究表明,全科医生有时会开出超出《英国国家处方集》指导的处方。随着全科医疗中持续努力改善处方行为,对于那些试图影响处方行为的人来说,了解这一决策过程的复杂性至关重要。这应有助于为改变该领域行为的策略的设计和实施提供信息。